Julian Robertson Really Likes Gilead Sciences

Hedge-fund titan Julian Robertson really likes Gilead Sciences (GILD). In an interview on CNBC today, Robertson explained why he is such a fan of the stock, despite protests that its hepatitis-c treatment costs too much: David Paul Morris/Bloomberg News I’m very proud to be a shareholder of Gilead. They have really solved the Hepatitis C [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.